| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ASO | Common Stock | Options Exercise | +1.83K | +1.79% | 104K | Jan 31, 2023 | Direct | F1 | ||
| transaction | ASO | Common Stock | Tax liability | -$30.9K | -544 | -0.52% | $56.80 | 104K | Jan 31, 2023 | Direct | |
| transaction | ASO | Common Stock | Options Exercise | $563K | +33.7K | +32.41% | $16.70 | 138K | Jan 31, 2023 | Direct | F2 |
| transaction | ASO | Common Stock | Options Exercise | $544K | +33K | +24% | $16.48 | 171K | Jan 31, 2023 | Direct | F2 |
| transaction | ASO | Common Stock | Options Exercise | $590K | +35.6K | +20.87% | $16.57 | 206K | Jan 31, 2023 | Direct | F2 |
| transaction | ASO | Common Stock | Sale | -$5.94M | -102K | -49.61% | $58.04 | 104K | Jan 31, 2023 | Direct | F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ASO | Restricted Stock Units | Options Exercise | $0 | -1.83K | -33.33% | $0.00 | 3.67K | Jan 31, 2023 | Common Stock | 1.83K | Direct | F1, F4, F5 | |
| transaction | ASO | Stock Options (Right to Buy) | Options Exercise | -$563K | -33.7K | -100% | $16.70 | 0 | Jan 31, 2023 | Common Stock | 33.7K | $16.70 | Direct | F2, F6 |
| transaction | ASO | Stock Options (Right to Buy) | Options Exercise | -$544K | -33K | -100% | $16.48 | 0 | Jan 31, 2023 | Common Stock | 33K | $16.48 | Direct | F2, F7 |
| transaction | ASO | Stock Options (Right to Buy) | Options Exercise | -$590K | -35.6K | -100% | $16.57 | 0 | Jan 31, 2023 | Common Stock | 35.6K | $16.57 | Direct | F2, F7 |
| Id | Content |
|---|---|
| F1 | Restricted stock units convert into common stock on a one-for-one basis. |
| F2 | The options exercised and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $57.85 to $58.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| F4 | Granted under the Company's 2020 Omnibus Incentive Plan (the "Plan"). |
| F5 | On March 31, 2021, the Reporting Person was granted 7,336 performance-based restricted stock units. These performance-based restricted stock units vest if certain performance criteria and/or Issuer stock price conditions are met and certified by the Issuer's compensation committee. Following certification of achievement of the performance criteria during fiscal 2021 by the Issuer's compensation committee on March 2, 2022, 25% of this grant vested on March 2, 2022, and the remaining 75% will vest in three equal annual installments beginning on January 31, 2023. |
| F6 | These time-based options are fully vested. |
| F7 | These time-based options previously granted under the Issuer's 2011 Unit Incentive Plan, or the 2011 Equity Plan, are fully vested due to a Change of Control (as defined in the 2011 Equity Plan) that resulted from the Issuer's secondary public offering that closed on May 10, 2021. |